Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $16.6 million.

  • Ultralife's Shares Outstanding (Weighted Average) rose 12.63% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year increase of 12.63%. This contributed to the annual value of $16.6 million for FY2024, which is 210.31% up from last year.
  • Ultralife's Shares Outstanding (Weighted Average) amounted to $16.6 million in Q3 2025, which was up 12.63% from $16.6 million recorded in Q2 2025.
  • Ultralife's 5-year Shares Outstanding (Weighted Average) high stood at $16.6 million for Q3 2025, and its period low was $16.0 million during Q1 2021.
  • In the last 4 years, Ultralife's Shares Outstanding (Weighted Average) had a median value of $16.4 million in 2024 and averaged $16.4 million.
  • As far as peak fluctuations go, Ultralife's Shares Outstanding (Weighted Average) skyrocketed by 264.54% in 2024, and later rose by 12.63% in 2025.
  • Over the past 4 years, Ultralife's Shares Outstanding (Weighted Average) (Quarter) stood at $16.0 million in 2021, then rose by 1.22% to $16.2 million in 2023, then rose by 2.1% to $16.6 million in 2024, then grew by 0.55% to $16.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $16.6 million for Q3 2025, versus $16.6 million for Q2 2025 and $16.6 million for Q1 2025.